These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28506805)

  • 21. Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study.
    Christensen JJ; Narverud I; Ruuth M; Heier M; Jauhiainen M; Ulven SM; Bogsrud MP; Kovanen PT; Halvorsen B; Oda MN; Wium C; Retterstøl K; Öörni K; Holven KB
    J Intern Med; 2021 Nov; 290(5):1083-1097. PubMed ID: 34506681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure, immunology, and cell reactivity of low density lipoprotein from umbilical vein of a newborn type II homozygote.
    Patsch W; Witztum JL; Ostlund R; Schonfeld G
    J Clin Invest; 1980 Jul; 66(1):123-9. PubMed ID: 7400306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol efflux from cultured skin fibroblasts in 12 patients clinically heterozygous for familial hypercholesterolemia.
    Esteva O; Baudet MF; Jacotot B
    Clin Chim Acta; 1986 Aug; 158(3):263-70. PubMed ID: 3769200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children.
    Tolani S; Pagler TA; Murphy AJ; Bochem AE; Abramowicz S; Welch C; Nagareddy PR; Holleran S; Hovingh GK; Kuivenhoven JA; Tall AR
    Atherosclerosis; 2013 Jul; 229(1):79-85. PubMed ID: 23684512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.
    May-Zhang LS; Yermalitsky V; Melchior JT; Morris J; Tallman KA; Borja MS; Pleasent T; Amarnath V; Song W; Yancey PG; Davidson WS; Linton MF; Davies SS
    J Biol Chem; 2019 Dec; 294(50):19022-19033. PubMed ID: 31666337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia.
    Guay SP; Brisson D; Munger J; Lamarche B; Gaudet D; Bouchard L
    Epigenetics; 2012 May; 7(5):464-72. PubMed ID: 22419126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux.
    Ottestad IO; Halvorsen B; Balstad TR; Otterdal K; Borge GI; Brosstad F; Myhre AM; Ose L; Nenseter MS; Holven KB
    J Nutr; 2006 Apr; 136(4):877-81. PubMed ID: 16549444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.
    Kang H; Song J; Cheng Y
    Int Immunopharmacol; 2024 Sep; 138():112622. PubMed ID: 38971111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients.
    Dedoussis GV; Maumus S; Choumerianou DM; Skoumas J; Pitsavos C; Stefanadis C; Visvikis-Siest S
    Genet Test; 2006; 10(3):192-9. PubMed ID: 17020471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia.
    Tada H; Okada H; Nohara A; Toh R; Harada A; Murakami K; Iino T; Nagao M; Ishida T; Hirata KI; Takamura M; Kawashiri MA
    Circ J; 2023 May; 87(6):806-812. PubMed ID: 36436874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.